Sefety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERMIONE non-interventional prospective study

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; pp. viii70 - viii71
Main Authors Jacquin, J.-P.P., Uwer, L., Savignoni, A., Ferrero, J.-M., Lortholary, A., Solub, D., Attar-Rabia, H., Deblay, S., Pibre, S., Belkacemi, Y.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy270.215